SREBF2 and non-small cell lung carcinoma: Lung cancer-related pleural effusion (LCPF), a common complication of lung cancer treatment, stimulates expression of SREBP2, which can induce pleural angiogenesis in patients and exacerbate advanced on-small cell lung cancer (NSCLC) with pleural effusion (Tsai et al., 2022).